Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 88137376 | 8813737 | 6 | F | 20120914 | 20160907 | 20120928 | 20160909 | EXP | CA-ROCHE-1136266 | ROCHE | 64.08 | YR | F | Y | 95.00000 | KG | 20160909 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 88137376 | 8813737 | 1 | PS | Tocilizumab | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125276 | 760 | MG | SOLUTION FOR INFUSION | |||||||
| 88137376 | 8813737 | 2 | SS | Tocilizumab | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125276 | 375 | MG | SOLUTION FOR INFUSION | |||||||
| 88137376 | 8813737 | 3 | SS | Tocilizumab | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125276 | 750 | MG | SOLUTION FOR INFUSION | |||||||
| 88137376 | 8813737 | 4 | SS | Tocilizumab | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | U | 125276 | 375 | MG | SOLUTION FOR INFUSION | |||||||
| 88137376 | 8813737 | 5 | C | TEMAZEPAM. | TEMAZEPAM | 1 | 0 | ||||||||||||
| 88137376 | 8813737 | 6 | C | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 88137376 | 8813737 | 7 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | 0 | ||||||||||||
| 88137376 | 8813737 | 8 | C | LORAZEPAM. | LORAZEPAM | 1 | 0 | ||||||||||||
| 88137376 | 8813737 | 9 | C | MIRAPEX | PRAMIPEXOLE DIHYDROCHLORIDE | 1 | 0 | ||||||||||||
| 88137376 | 8813737 | 10 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 88137376 | 8813737 | 11 | C | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 88137376 | 8813737 | 12 | C | METHOTREXATE. | METHOTREXATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 88137376 | 8813737 | 1 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 88137376 | 8813737 | OT |
| 88137376 | 8813737 | HO |
| 88137376 | 8813737 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 88137376 | 8813737 | Anaemia | |
| 88137376 | 8813737 | Arthralgia | |
| 88137376 | 8813737 | Arthritis infective | |
| 88137376 | 8813737 | Back pain | |
| 88137376 | 8813737 | Cystitis | |
| 88137376 | 8813737 | Decreased appetite | |
| 88137376 | 8813737 | Diarrhoea | |
| 88137376 | 8813737 | Drug dose omission | |
| 88137376 | 8813737 | Joint arthroplasty | |
| 88137376 | 8813737 | Movement disorder | |
| 88137376 | 8813737 | Muscle rupture | |
| 88137376 | 8813737 | Musculoskeletal discomfort | |
| 88137376 | 8813737 | Musculoskeletal stiffness | |
| 88137376 | 8813737 | Nausea | |
| 88137376 | 8813737 | Procedural complication | |
| 88137376 | 8813737 | Rheumatoid arthritis | |
| 88137376 | 8813737 | Sepsis | |
| 88137376 | 8813737 | Skeletal injury | |
| 88137376 | 8813737 | Vomiting | |
| 88137376 | 8813737 | Weight decreased | |
| 88137376 | 8813737 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 88137376 | 8813737 | 1 | 20110527 | 0 | ||
| 88137376 | 8813737 | 2 | 20120116 | 0 | ||
| 88137376 | 8813737 | 3 | 20130319 | 0 | ||
| 88137376 | 8813737 | 4 | 20131210 | 20160118 | 0 |